Benchmarks

OpenAI Releases GPT-Rosalind for Drug Discovery

OpenAI Releases GPT-Rosalind for Drug Discovery

OpenAI launched GPT-Rosalind on April 16, a frontier reasoning model for drug discovery that outranked human experts on RNA prediction and competes directly with Google DeepMind's AlphaFold.